Sign In
Buy CPRX
$31.28
+0.0100 (+0.0320%)
At Close: Jun 03, 2026
Is Now the Time to Buy This Risky Stock With Huge Upside Potential?
03:07pm, Saturday, 04'th Jun 2022 The Motley Fool
Having a small drug development pipeline is a big risk, but it also leaves the door open potentially for big gains.
Is Now the Time to Buy This Risky Stock With Huge Upside Potential?
11:07am, Saturday, 04'th Jun 2022
Having a small drug development pipeline is a big risk, but it also leaves the door open potentially for big gains.
Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences
12:03pm, Tuesday, 17'th May 2022 GlobeNewswire Inc.
CORAL GABLES, Fla., May 17, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and
Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences
08:03am, Tuesday, 17'th May 2022
CORAL GABLES, Fla., May 17, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and c
Catalyst Pharmaceuticals (CPRX) Q1 Earnings Miss, Revenues Up Y/Y
03:20pm, Wednesday, 11'th May 2022 Zacks Investment Research
Catalyst's (CPRX) first-quarter 2022 earnings miss estimates while revenues meet the same.
Catalyst Pharmaceuticals (CPRX) Q1 Earnings Miss, Revenues Up Y/Y
12:48pm, Wednesday, 11'th May 2022
Catalyst's (CPRX) first-quarter 2022 earnings miss estimates while revenues meet the same.
Catalyst Pharmaceuticals, Inc. (CPRX) CEO Patrick McEnany on Q1 2022 Results - Earnings Call Transcript
11:43am, Wednesday, 11'th May 2022
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX ) Q1 2022 Earnings Conference Call May 11, 2022 8:30 AM ET Company Participants Ali Grande - Vice President, Chief Financial Officer and Treasurer Patrick M
Catalyst Pharmaceutical (CPRX) Misses Q1 Earnings and Revenue Estimates
09:25pm, Tuesday, 10'th May 2022 Zacks Investment Research
Catalyst (CPRX) delivered earnings and revenue surprises of -14.29% and 0.19%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Catalyst Pharmaceuticals Reports Record First Quarter 2022 Financial Results And Provides Corporate Update
08:11pm, Tuesday, 10'th May 2022 GlobeNewswire Inc.
Achieved Record Revenues of more than $43 Million, a 42.7% Increase YoY
Catalyst Pharmaceutical (CPRX) Misses Q1 Earnings and Revenue Estimates
06:49pm, Tuesday, 10'th May 2022
Catalyst (CPRX) delivered earnings and revenue surprises of -14.29% and 0.19%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
01:23pm, Tuesday, 10'th May 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Pfizer Acquires Biohaven For $11B
Pfizer Inc (NYSE: PFE) will acquire Biohaven Pharmaceutical Hold
Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Lags Revenue Estimates
09:45pm, Monday, 09'th May 2022 Zacks Investment Research
Enanta Pharmaceuticals (ENTA) delivered earnings and revenue surprises of -13.99% and 8.26%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Drug/Biotech Stocks' Q1 Earnings on May 10: EXEL, BHC & More
03:37pm, Monday, 09'th May 2022 Zacks Investment Research
Let's look at the five biotech/drug companies that are slated to release quarterly results on May 10.
Drug/Biotech Stocks' Q1 Earnings on May 10: EXEL, BHC & More
12:47pm, Monday, 09'th May 2022
Let's look at the five biotech/drug companies that are slated to release quarterly results on May 10.
Catalyst Pharmaceuticals to Report First Quarter 2022 Financial Results on May 10, 2022
12:03pm, Monday, 25'th Apr 2022 GlobeNewswire Inc.
The Company to Host a Conference Call and Webcast on May 11, 2022, at 8:30 AM ET The Company to Host a Conference Call and Webcast on May 11, 2022, at 8:30 AM ET
